Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BioCaPHeal

Financiado

Cerrado

Flame-made calcium phosphate nanoparticles for biological drug delivery toward h...

Flame-made calcium phosphate nanoparticles for biological drug delivery toward healing chronic wound The increasing number of chronic wound cases, most frequently attributed to antibiotic-resistant bacterial infections, has set an urgent alarm since it causes low quality of life and even fatal complications to thousands of patien... ver más

28/02/2026

207K€

Presupuesto del proyecto: 207K€

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-12-01

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 Expected Outcome:

I+D

Cerrada

0% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

206.89K€ | Lider

Proyectos interesantes

SNFWD

Medical Technol...

Nanotechnology

163K€ Cerrado

MAT2015-64831-R

Nanotechnology

Medical Technol...

363K€ Cerrado

MOZART

Nanotechnology

Medical Technol...

5M€ Cerrado

INTO

Medical Technol...

Nanotechnology

183K€ Cerrado

CYCLON HIT

Nanotechnology

Medical Technol...

4M€ Cerrado

PID2019-106436RB-I00

Nanotechnology

Medical Technol...

97K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 26 meses Fecha Inicio: 2023-12-01
Fecha Fin: 2026-02-28

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 207K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The increasing number of chronic wound cases, most frequently attributed to antibiotic-resistant bacterial infections, has set an urgent alarm since it causes low quality of life and even fatal complications to thousands of patients as well as burdens the healthcare systems globally. Antimicrobial biological drugs, also called biologics, are proposed to address the emerging and unmet threat of antibiotic-resistant bacteria in wound infections by developing antibiotic-free treatments with low immunological risk. Despite having maximal antimicrobial effect, biologics efficiency in infection treatment and wound healing is compromised due to their limited circulation half-life and susceptibility to environment and wound related factors. Hybrid nanoformulations (HNs) based on inorganic nanoparticles (NPs) are developed to perform biologics delivery by securing the integrity of their vulnerable structure and efficiency while they exhibit great potential in biomedicine as drug nanocarriers due to their stability, small size, and extremely high surface area. Here, we propose the synthesis of biocompatible and healing-promoting Calcium Phosphate (CaP) NPs with a nanomanufacturing process famous for its scalability and reproducibility, Flame Spray Pyrolysis. The as-prepared CaP NPs will be loaded with the biologics, peptide LL-37 and enzyme Lysozyme, to form novel hybrid drug delivery nanosystems. Synthesis parameters of CaP NPs and HNs nanomanufacturing protocols will be studied and their physicochemical characterization will be performed. The stability, the antimicrobial activity and the cytocompatibility of the HNs will be examined with in-vitro assays. Finally, the effectiveness of HNs in wound infections treatment and wound healing promotion will be tested ex-vivo. This project will provide fundamental insights on biological drug loading parameters on nanocarriers to facilitate rapid translation to clinics, after the intellectual property is protected.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores